Estrella Immunopharma Inc. (ESLA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Estrella Immunopharma Inc...

NASDAQ: ESLA · Real-Time Price · USD
1.20
0.00 (0.00%)
At close: Sep 29, 2025, 10:09 AM

Estrella Immunopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2022 Jun 30, 2022
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-8.85M -7.31M -1.57M -1.69M
Interest Income
n/a n/a 654.07K 1.43K
Pretax Income
-8.85M -7.31M -915.46K -1.69M
Net Income
-8.85M -7.31M -996.1K -1.69M
Selling & General & Admin
2.44M 3.2M 1.37M 296.25K
Research & Development
6.41M 4.11M n/a 1.39M
Other Expenses
n/a n/a -201.31K n/a
Operating Expenses
8.85M 7.31M 1.57M 1.69M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
8.85M 7.31M 1.57M 1.69M
Income Tax Expense
1.69K 1.63K 80.65K -235.14K
Shares Outstanding (Basic)
36.68M 35.2M 5.76M 5.85M
Shares Outstanding (Diluted)
36.68M 35.2M 5.76M 5.85M
EPS (Basic)
-0.25 -0.21 -0.17 -0.29
EPS (Diluted)
-0.25 -0.21 -0.17 -0.29
EBITDA
-8.85M -7.31M -915.46K -247.72K
EBIT
-8.85M -7.31M -915.46K -247.72K
Depreciation & Amortization
-39.59K n/a 228.49K 236.56K